Clarithromycin Tablet, Film Coated, Extended Release
Product Images NDC 62135-883
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 62135-883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Clarithromycin Er Tablets 500 mg Graph 1)
This information shows the mean plasma concentration (mcg/mL) of Clarithromycin and Clarithromycin extended-release at different times after dosing. The concentrations are measured over a 24-hour period for both formulations: Clarithromycin extended-release at 2 x 500 mg every 24 hours, and Clarithromycin at 500 mg every 12 hours.*
Image Description (Clarithromycin Er Tablets 500 mg Logo)
Image Description (Clarithromycin Er Tablets 500 mg Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.